FDA inspection
University of Utah Cell Therapy and Regenerative Medicine: FDA inspection ending Sep 30, 2024
FDA inspection 1229003 · Voluntary Action Indicated (VAI) · Salt Lake City, UT
Key facts
| Inspection ID | 1229003 |
|---|---|
| Firm | University of Utah Cell Therapy and Regenerative Medicine |
| FEI number | 3004471729 |
| Address | 675 S Arapeen Dr Ste 300 |
| City | Salt Lake City |
| State | UT |
| ZIP | 84108 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data